We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$110M
Cap. Flow %
7.96%
Top 10 Hldgs %
26.02%
Holding
618
New
82
Increased
295
Reduced
154
Closed
21

Top Buys

Rank Stock Value
1
OBDE
Blue Owl Capital Corporation III
OBDE
+$8.93M
2
AZN icon
AstraZeneca
AZN
+$4.24M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.9M
4
TEL icon
TE Connectivity
TEL
+$3.61M
5
FSK icon
FS KKR Capital
FSK
+$3.54M

Top Sells

Rank Stock Value
1
OBDC icon
Blue Owl Capital
OBDC
+$10.9M
2
JNJ icon
Johnson & Johnson
JNJ
+$4.45M
3
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$2.17M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$2.14M
5
ZM icon
Zoom
ZM
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 16.04%
3 Healthcare 10.13%
4 Consumer Discretionary 4.67%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMCV icon
551
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
$207K 0.02%
2,954
+147
+5% +$10.4K
VIS icon
552
Vanguard Industrials ETF
VIS
$8.07B
$207K 0.02%
882
– –
CF icon
553
CF Industries
CF
$19.4B
$207K 0.02%
+2,798
New +$217K
RQI icon
554
Cohen & Steers Quality Income Realty Fund
RQI
$1.72B
$207K 0.02%
17,724
-699
-4% -$7.94K
AXON
555
Axon Enterprise
AXON
$44.6B
$206K 0.02%
+701
New +$209K
TEVA icon
556
Teva Pharmaceuticals
TEVA
$40.1B
$205K 0.01%
12,646
+196
+2% +$3.02K
FTLS icon
557
First Trust Long/Short Equity ETF
FTLS
$2.45B
$204K 0.01%
+3,261
New +$199K
FOCT icon
558
FT Vest US Equity Buffer ETF October
FOCT
$1.15B
$204K 0.01%
+4,900
New +$200K
DSL
559
DoubleLine Income Solutions Fund
DSL
$1.22B
$203K 0.01%
16,228
– –
GIGB icon
560
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$970M
$201K 0.01%
+4,452
New +$201K
EA icon
561
Electronic Arts
EA
$52.3B
$201K 0.01%
+1,439
New +$190K
MKSI icon
562
MKS Inc
MKSI
$18.3B
$200K 0.01%
+1,532
New +$193K
KYN icon
563
Kayne Anderson Energy Infrastructure Fund
KYN
$2.45B
$200K 0.01%
19,336
+3,000
+18% +$29.6K
CCSO icon
564
Carbon Collective Climate Solutions US Equity ETF
CCSO
$45.7M
$195K 0.01%
10,516
– –
CNOB icon
565
Center Bancorp
CNOB
$1.65B
$189K 0.01%
10,000
– –
MYD
566
DELISTED
BlackRock MuniYield Fund
MYD
$184K 0.01%
17,000
+2,000
+13% +$21.5K
CSQ icon
567
Calamos Strategic Total Return Fund
CSQ
$3.16B
$183K 0.01%
10,855
– –
IOVA icon
568
Iovance Biotherapeutics
IOVA
$2.03B
$180K 0.01%
+22,500
New +$241K
SPFF icon
569
Global X SuperIncome Preferred ETF
SPFF
$140M
$175K 0.01%
19,017
– –
RIV
570
RiverNorth Opportunities Fund
RIV
$309M
$154K 0.01%
12,554
– –
PIM
571
Franklin Master Intermediate Income Trust
PIM
$149M
$152K 0.01%
47,200
– –
MITT
572
TPG Mortgage Investment Trust
MITT
$228M
$148K 0.01%
22,300
+2,500
+13% +$15.9K
BGH
573
Barings Global Short Duration High Yield Fund
BGH
$282M
$145K 0.01%
10,000
– –
MVT
574
DELISTED
BlackRock MuniVest Fund II
MVT
$141K 0.01%
12,763
+64
+0.5% +$682
AVK
575
Advent Convertible and Income Fund
AVK
$534M
$139K 0.01%
11,996
– –
21 22
23
24 25

Similar funds

GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.25B AUM 12.03% 1-Year Est. Return
LIA
Limestone Investment Advisors New York $1.25B AUM 25.43% 1-Year Est. Return
LMGAM
Liberty Mutual Group Asset Management Boston, Massachusetts $1.25B AUM 45.27% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return
FFM
Fullerton Fund Management Singapore $1.25B AUM 76.88% 1-Year Est. Return
TCA
Teewinot Capital Advisers New York $1.25B AUM 32.55% 1-Year Est. Return
DP
Dundas Partners Edinburgh, United Kingdom $1.25B AUM 13.92% 1-Year Est. Return

Transcend Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Transcend Capital Advisors held 618 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors deployed $110M of net new capital in Q2 2024, opening 82 new positions and adding to 295 existing holdings. Its largest new stake was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Blue Owl Capital, an estimated $10.9M trimmed.

  • Transcend Capital Advisors's largest Q2 2024 buy was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.
  • Transcend Capital Advisors added most to AstraZeneca in Q2 2024, an estimated $4.24M increase.
  • Transcend Capital Advisors's biggest Q2 2024 reduction was Blue Owl Capital, cutting an estimated $10.9M.
  • Transcend Capital Advisors fully exited Crane Co in Q2 2024, selling an estimated $480K.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $1.38B portfolio in Q2 2024.
  • Transcend Capital Advisors opened 82 new positions and closed 21 in Q2 2024.
  • Transcend Capital Advisors's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Transcend Capital Advisors's 13F filing for Q2 2024, filed 2 Jul 2024.